Publicaciones en colaboración con investigadores/as de Public Health England (15)

2023

  1. Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3)

    Neuro-Oncology, Vol. 25, Núm. 3, pp. 580-592

2022

  1. Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000–14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries

    The Lancet Child and Adolescent Health, Vol. 6, Núm. 6, pp. 409-431

2021

  1. The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3)

    Neuro-Oncology, Vol. 23, Núm. 10, pp. 1765-1776

2019

  1. Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: Implications for adult vaccination

    Thorax, Vol. 74, Núm. 5, pp. 473-482

2018

  1. Changing geographical patterns and trends in cancer incidence in children and adolescents in Europe, 1991–2010 (Automated Childhood Cancer Information System): a population-based study

    The Lancet Oncology, Vol. 19, Núm. 9, pp. 1159-1169

  2. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

    The Lancet, Vol. 391, Núm. 10125, pp. 1023-1075

  3. Urine Metabolic Signatures of Multiple Environmental Pollutants in Pregnant Women: An Exposome Approach

    Environmental Science and Technology, Vol. 52, Núm. 22, pp. 13469-13480

2017

  1. Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405–413](S0090825816314974)(10.1016/j.ygyno.2016.10.019)

    Gynecologic Oncology

  2. Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396–404](S009082581631575X)(10.1016/j.ygyno.2016.11.019)

    Gynecologic Oncology

  3. Geographical variability in survival of European children with central nervous system tumours

    European Journal of Cancer, Vol. 82, pp. 137-148

  4. Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study

    European Journal of Cancer, Vol. 84, pp. 335-353

  5. Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries

    The Lancet Haematology, Vol. 4, Núm. 5, pp. e202-e217

2015

  1. Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

    The Lancet, Vol. 385, Núm. 9972, pp. 977-1010

2014

  1. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study

    The Lancet Oncology, Vol. 15, Núm. 1, pp. 23-34

  2. Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project

    Cancer Epidemiology, Vol. 38, Núm. 6, pp. 670-678